ADPT Adaptive Biotechnologies Inc.: Net earnings per share for the last 12 months
Adaptive Biotechnologies relies on competent management and transparent research data, although the market is assessing its ability to reduce costs. The annual percentage change in EPS TTM reflects the connection between these aspects and the company's environmental responsibility regarding the control of laboratory emissions. Meanwhile, a unique genomic database ensures high partner loyalty, while the 16.10 metric serves as the target level.
Adaptive Biotechnologies Corp - analytical breakdowns and key metrics (ADPT)
- market value and analyst target forecast:
- company stock capitalization data:
- book capitalization data:
- debt burden and liquidity indicators:
Debt to Capital Adaptive Biotechnologies|ADPT - Long-Term Debt to Capital|Short-Term Debt to Capital Adaptive Biotechnologies Inc.|ADPT - Company Aggregate Debts|Debt to Book Value Ratio Adaptive Biotech|ADPT - Company Long-Term Debts|Company Short-Term Debts Adaptive Biotechnologies|Critical Liquidity Ratio adaptivebiotech.com
- earnings and multiples data:
ADPT - Net Income|Future Net Profit Adaptive Biotechnologies|ADPT - P/E Multiple|Market Cap to Projected Earnings Adaptive Biotech|ADPT - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotech|ADPT - Operating profit EBITDA|Net earnings per one share for the last twelve months Adaptive Biotechnologies|ADPT - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months adaptivebiotech.com|ADPT - Earnings growth in current year|Net earnings per share growth forecast for next year Adaptive Biotechnologies
- revenue and sales details:
Fundamental company valuation:adaptivebiotech.com, ADPT
High R&D expenditures for immune tests at Adaptive Biotechnologies (ADPT) and slow adoption by insurance companies are pressuring net income. By analyzing this rolling year-over-year EPS growth chart, an investor assesses the rate of change in earnings per share relative to the previous year, which allows them to distinguish market noise from real value dynamics and identify critical points of business growth deceleration.
Competitor analysis for Adaptive Biotechnologies
argenx.com (ARGX) - Net earnings per share for the last 12 months|BioNTech (BNTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Abivax Corp|Net earnings per share for the last 12 months ADMA|Net earnings per share (EPS TTM) Protagonist Corp|Earnings per share for the last twelve months Immunovant, Inc. (IMVT)|kiniksa.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) GRFS (Grifols)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|Aurinia Pharma - Net earnings per share (EPS TTM)|BCRX - Net earnings per share (EPS TTM)|VERA: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months DNTH|PHVS (Pharvaris) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) AbCellera Biologics Inc|Earnings per share for the last twelve months Tourmaline Corp (TRML)|PGEN: Earnings per one share for the last 12 months|Pharming Group N.V. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters NKTR (nektar.com)|Upstream Bio - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Zenas Bio ZBIO|IMNM (Immunome Corp) - Net earnings per share for the last 12 months|GOSS (Gossamer Bio Corp.) - Earnings per share for the last twelve months|KALV (KalVista Pharmaceuticals) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months septerna.com SEPN|Net earnings per share for the last 12 months PVLA (Pieris Pharmaceuticals, Inc.)|SVRA (Savara Inc) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) RIGL (Rigel Pharmaceuticals Inc)|AnaptysBio Inc. - Earnings per share for the last twelve months|Astria Therapeutics - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters engene.com ENGN|RAPT Therapeutics, Inc. (RAPT) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Aerovate Therapeutics (JBIO)|Net earnings per share for the last 12 months ACRS|KYTX (Kyverna Therapeutics, Inc) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) TLSA|CABA - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) VTYX (Ventyx Biosciences, Inc.)|THTX - Net earnings per share for the last 12 months|Avalo Therapeutics Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ELDN (Eledon Pharmaceuticals, Inc)|Agenus (AGEN) - Earnings per share for the last twelve months|Earnings per share for the last 12 months CLYM|Earnings per share for the last twelve months Zura Bio Limited|Net earnings per one share for the last twelve months aTyr Pharma Inc ATYR|Earnings per share for the last twelve months Adagene (ADAG)|Earnings per share for the last twelve months IMA (ikenaoncology.com)|Earnings per share for the last twelve months Shattuck Labs STTK|Equillium Inc (EQ) - Net earnings per one share for the last twelve months|Connect Pharma - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Immunic, Inc. (IMUX)|ATRA: Net earnings per share (EPS TTM)|IFRX - Net earnings per share for the last four quarters|XFOR (X4 Pharmaceuticals) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Adicet ACET|Earnings per share for the last twelve months Celularity Inc. (CELU)|Net earnings per share for the last four quarters INmune Bio Inc|Net earnings per share (EPS TTM) BRNS (Barinthus Bio)|Net earnings per share (EPS TTM) Kezar Life Sciences Inc KZR|SAB Biotherapeutics - Net earnings per share (EPS TTM)|AKTX (akaritx.com) - Earnings per share for the last 12 months|enlivex.com (ENLV) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months QTTB (Q32 Bio)|Net earnings per share for the last 12 months GOVX|EDSA (Edesa Biotech Corp) - Earnings per share for the last four quarters|Earnings per share for the last twelve months iBio, Inc. (IBIO)|CARM: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) XTLB (XTL Biopharmaceuticals Ltd.)|Earnings per share for the trailing year BOLT|HCW Biologics Inc - Net earnings per share (EPS TTM)|APVO - Net earnings per share (EPS TTM)|AIM ImmunoTech (AIM) - Earnings per share for the last twelve months|Aditxt, Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months GRI Bio|Net earnings per share for the last 12 months XORTX Therapeutics Inc (XRTX)|Net earnings per share (EPS TTM) HIND|Net earnings per share (EPS TTM) Revelation Biosciences Corp (REVB)|Indaptus Therapeutics - Net earnings per share for the last 12 months|Earnings per share for the trailing year SCNI|CalciMedica Corp - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Affimed AFMD|allakos.com (ALLK) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months HOOKIPA Pharma|Earnings per share for the last twelve months IGM Biosciences Inc.|Net earnings per share for the last 12 months iteostherapeutics.com (ITOS)|Net earnings per share for the last 12 months OCEA (Ocean Biomedical)|Net earnings per share (EPS TTM) TC BioPharm (Holdings) Plc (TCBP)|Earnings per share for the last twelve months Third Harmonic Bio, Inc THRD
